Lecture 3b: Liver disease Flashcards
Length of preicteric phase
3 - 10 days
4 clinical manifestations of the preicteric phase
Fatigue
Nausea
Poor appetite
Vague R Upper quadrant pain
4 clinical manifestations of icteric phase
Production of dark urine
Jaundice appears
Hepatic tenderness
Symptoms worse
4 general manifestations of liver disease relating to oral health
Anorexia
Dysgeusia
Weight loss
Easy bruising/petechia
Risk of acquiring hepatitis as a dentist relative to general population
3 - 10 times
To whom are HBV booster doses given?
Only to people who did not respond to the primary vaccination series
HBV exposure protocol for vaccinated care provider (i.e. if stuck by a contaminated needle)
Should be tested for adequate titer of anti-HBs if levels are unknown
• Adequate –> nothing further is required
• Inadequate –> immediately receive an injection of HBIG and vaccine booster dose (30 % risk of contracting HBV infection from HBV carriers)
HBV exposure protocol for unvaccinated persons
Immediate HBIG injection and vaccine
HCV exposure protocol
- No postexposure protocol or vaccine is available
- Source person = baseline testing for anti HCV
- Exposed persons receive baseline and f/u testing at 6 mo for anti HCV and liver enzyme activity
4 analgesics to avoid in patient with liver disease
NSAIDs (incl. acetaminophen, aspirin)
Codeine
Meperidine
2 antibiotics to avoid in patient with liver disease
Metronidazole
Vancomycin
Antibiotic prophylaxis recommendations for patients with liver disease
Not recommended
However, patients with severe liver disease may be more susceptible tor infection
Anesthesia recommendations for patients with liver disease
Higher doses may be required to achieve adequate anesthesia in presence of alcoholic liver disease (must know liver function)
Epinephrine (1:100,000, no more than 2 carpules) for local generally not associated with problems, but monitor closely (especially if portal hypertension)
Anti-anxiety medication to avoid in patient with liver disease
Benzodiazepines
Bleeding considerations for patient with liver disease
May need vitamin K and/or platelet or clotting factor replacement to reduce risk of post-surgical bleeding